Internal Medicine, Medical Oncology · New York, NY
NPI
1477644896
Since 2006
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
1275 York Ave
New York, NY, 10021
Phone (646) 227-3275
Groups this clinician bills Medicare through
Medicare paid, 2024
$139K
1,155 services
Medicare patients, 2024
299
Average age 75
Drug cost, 2024
$2.0M
1,758 prescriptions
Company payments, 2025
$13K
From 7 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Eileen O'Reilly was code 99215 (office e&m - established), 842 times for 220 patients. In total Eileen O'Reilly billed 1,155 services in 12 codes, and Medicare paid $139K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-04-07.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Office | 842 | 220 | $124.79 | $105K |
| 99214 Office E&M - Established | Office | 172 | 104 | $90.87 | $16K |
| 99205 Office E&M - New | Office | 87 | 87 | $155.65 | $14K |
| 99233 Hospital E&M - Subsequent | Facility | 24 | 12 | $102.01 | $2,448 |
By year: 2022 $115K for 965 services; 2023 $127K for 1,063 services; 2024 $139K for 1,155 services.
Medicare prescription drug claims, 2024
In 2024, the drug Eileen O'Reilly prescribed most often to Medicare patients was Creon (Lipase/Protease/Amylase), with 294 prescriptions and refills. In total Eileen O'Reilly wrote 1,758 Medicare prescriptions that cost $2.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Creon Lipase/Protease/Amylase | 294 | 388 | 77 | $675K |
| Pantoprazole Sodium Generic | 204 | 333 | 67 | $2,765 |
| Zenpep Lipase/Protease/Amylase | 184 | 270 | 50 | $633K |
| Xarelto Rivaroxaban | 85 | 108 | 20 | $60K |
| Dexamethasone Generic | 84 | 87 | 54 | $912 |
| Ondansetron Hcl Generic | 84 | 88 | 56 | $867 |
| Olanzapine Generic | 58 | 70 | 23 | $1,015 |
| Prochlorperazine Maleate Generic | 51 | 51 | 30 | $858 |
| Oxycodone Hcl Generic | 49 | 49 | 22 | $234 |
| Fentanyl Generic | 38 | 38 | 17 | $3,824 |
| Potassium Chloride Generic | 37 | 41 | 19 | $326 |
| Lorazepam Generic | 34 | 34 | 17 | $115 |
| Diphenoxylate-Atropine Diphenoxylate Hcl/Atropine | 28 | 28 | 14 | $403 |
| Lynparza Olaparib | 27 | 30 | Under 11 | $447K |
| Sucralfate Generic | 25 | 29 | Under 11 | $1,596 |
Brand drugs: - claims; generic drugs: 1,062 claims; opioid claims: 116.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Eileen O'Reilly $13K ($13K in general payments such as food, travel and fees) from 7 companies. The largest payer was Corcept Therapeutics with $6,853.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.